Ethic Inc. Voyager Therapeutics, Inc. Transaction History
Ethic Inc.
- $5.89 Billion
- Q3 2025
A detailed history of Ethic Inc. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Ethic Inc. holds 38,353 shares of VYGR stock, worth $193,682. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,353
Previous 41,417
7.4%
Holding current value
$193,682
Previous $128,000
38.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VYGR
# of Institutions
119Shares Held
32.7MCall Options Held
32.9KPut Options Held
22.7K-
Black Rock Inc. New York, NY5.31MShares$26.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.8MShares$24.2 Million0.26% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$19.8 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$16.2 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$7.45 Million0.24% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $195M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...